2m 2m 2m 2m 2m 2m 2m
Vistagen Thera (VTGN)
NASDAQ
$0.57+$0.010 (+1.77%)
Price as of Jun 03, 2026 6:58 PM EDT- $25.0MMarket Cap
- -75.73%1-Year Change
- BiotechnologyIndustry
Vistagen Thera (VTGN)
$0.57+$0.010 (+1.77%)
Annual
Quarterly
03/31/2025 | 03/31/2024 | 03/31/2023 | 03/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 486,000 -54.32% | 1.1M +3,961.07% | 26,200 +31.66% | 19,900 -98.17% | |
Cost of Revenue | 120,000 -29.41% | 170,000 N/A | N/A N/A | N/A N/A | |
Gross Profit | 366,000 -59.06% | 894,000 +3,312.21% | 26,200 +31.66% | 19,900 -98.17% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -39.4M +96.66% | -20.0M -54.88% | -44.4M +25.33% | -35.4M +183.80% | |
Depreciation and Amortization Expense | 150,000 +18.11% | 127,000 -1.93% | 129,500 -15.64% | 153,500 +30.53% | |
Total Operating Expenses | 56.5M +65.64% | 34.1M -42.27% | 59.0M +20.77% | 48.9M +156.99% | |
Operating Profit | -56.0M +69.51% | -33.0M -44.29% | -59.3M +24.05% | -47.8M +166.42% | |
Interest Income | 5,000 -98.40% | 312,000 N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 5,000 -98.40% | 312,000 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 4.6M +35.99% | 3.4M +12,690.08% | 26,200 N/A | 0 -100.00% | |
Income before Taxes | -51.4M +75.12% | -29.4M -50.44% | -59.2M +24.04% | -47.8M +166.34% | |
Income Taxes | 7,000 +75.00% | 4,000 -32.20% | 5,900 +73.53% | 3,400 +30.77% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -51.4M +75.12% | -29.4M -50.44% | -59.2M +24.05% | -47.8M +166.32% | |
Net Income from Continuing Operations Applicable to Common | -51.4M +75.12% | -29.4M -50.45% | -59.2M +21.64% | -48.7M +15.09% | |
Basic EPS and Net Income | -1.67 +9.87% | -1.52 -82.14% | -8.51 +3,304.00% | -0.25 -48.98% | |
Diluted EPS and Net Income | -1.67 +9.87% | -1.52 -82.14% | -8.51 +3,304.00% | -0.25 -48.98% | |
Basic Weighted Average Shares | 30.9M +59.53% | 19.4M +178.13% | 7.0M -96.49% | 198.0M +129.85% | |
Diluted Weighted Average Shares | 30.9M +59.53% | 19.4M +178.13% | 7.0M -96.49% | 198.0M +129.85% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 67.1M -43.67% | 119.2M +616.25% | 16.6M -75.58% | 68.1M -33.92% | |
Short-Term Investments | 13.4M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 80.5M -32.46% | 119.2M +616.25% | 16.6M -75.58% | 68.1M -33.92% | |
Total Current Assets | 82.1M -31.98% | 120.7M +589.26% | 17.5M -75.34% | 71.0M -31.81% | |
Accumulated Depreciation | 1.4M +11.96% | 1.3M +5.08% | 1.2M -5.94% | 1.3M +9.94% | |
Property and Plant and Equipment and Net | 476,000 +9.43% | 435,000 -14.25% | 507,300 +22.45% | 414,300 +12.77% | |
Total Long-Term Assets | 454,000 -57.17% | 1.1M -13.16% | 1.2M +38.31% | 882,500 -1.55% | |
Total Assets | 84.3M -31.79% | 123.7M +486.33% | 21.1M -71.75% | 74.6M -31.07% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 0 -100.00% | 105,300 N/A | N/A N/A | |
Total Current Liabilities | 12.6M +146.18% | 5.1M +12.16% | 4.6M -20.78% | 5.8M +37.62% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 105,300 N/A | N/A N/A | |
Total Long-Term Liabilities | 1.3M -71.75% | 4.7M +6.69% | 4.4M +6.70% | 4.2M -65.63% | |
Total Liabilities | 14.0M +48.94% | 9.4M +3.97% | 9.0M -9.26% | 9.9M -39.10% | |
Retained Earnings | -407.6M +14.43% | -356.2M +8.98% | -326.9M +22.14% | -267.6M +21.73% | |
Total Stockholders Equity | 70.4M -38.41% | 114.3M +846.08% | 12.1M -81.33% | 64.7M -29.64% | |
Total Shares Outstanding | 29.0M +7.29% | 27.0M +269.49% | 7.3M -96.46% | 206.7M +14.34% | |
Cash Flow | |||||
Cash from Operating Activities | -42.1M +63.08% | -25.8M -48.08% | -49.7M +9.85% | -45.3M +274.84% | |
Capital Expenditures | N/A N/A | 0 -100.00% | 528,300 +163.62% | 200,400 -27.23% | |
Cash from Investing Activities | -13.1M +21,454.10% | -61,000 -91.76% | -740,300 +269.41% | -200,400 -27.23% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 3.2M -97.50% | 128.4M +12,419.10% | -1.0M -109.94% | 10.5M -90.81% | |
Financials Ratio | |||||
Gross Margin | 75.31% -10.37% | 84.02% N/A | N/A N/A | N/A N/A | |
Operating Margin | -11,517.08% +271.10% | -3,103.48% -98.63% | -226,213.74% -5.78% | -240,094.97% +14,486.06% | |
Return on Assets | -49.44% +21.86% | -40.57% -67.22% | -123.78% +137.03% | -52.22% +66.05% | |
Return on Equity | -55.68% +19.83% | -46.47% -69.88% | -154.30% +153.11% | -60.96% +46.59% | |
Revenue Growth | -54.32% -101.37% | 3,961.07% +12,411.94% | 31.66% +132.25% | -98.17% -102.79% | |
Current Ratio | 6.51 -72.37% | 23.55 +514.51% | 3.83 -68.87% | 12.32 -50.45% | |
Cash Ratio | 5.32 -77.12% | 23.26 +538.56% | 3.64 -69.18% | 11.82 -51.98% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.02 N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.01 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow